David Linetsky Sells 6,106 Shares of Phreesia (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) insider David Linetsky sold 6,106 shares of the business’s stock in a transaction dated Thursday, January 8th. The stock was sold at an average price of $17.01, for a total transaction of $103,863.06. Following the completion of the sale, the insider owned 231,723 shares in the company, valued at $3,941,608.23. This represents a 2.57% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

David Linetsky also recently made the following trade(s):

• On Wednesday, December 17th, David Linetsky sold 94 shares of Phreesia stock. The stock was sold at an average price of $16.49, for a total transaction of $1,550.06.
• On Friday, October 17th, David Linetsky sold 2,059 shares of Phreesia stock. The shares were sold at an average price of $22.36, for a total transaction of $46,039.24.

Phreesia Price Performance

Shares of PHR stock traded down $0.10 during trading hours on Monday, hitting $17.14. The company’s stock had a trading volume of 760,277 shares, compared to its average volume of 1,018,096. The company has a current ratio of 2.44, a quick ratio of 2.44 and a debt-to-equity ratio of 0.01. The business has a fifty day moving average of $18.95 and a 200-day moving average of $23.69. Phreesia, Inc. has a twelve month low of $15.41 and a twelve month high of $32.76. The stock has a market cap of $1.03 billion, a price-to-earnings ratio of -171.33 and a beta of 0.61.

Phreesia (NYSE:PHR) last posted its earnings results on Monday, December 8th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.11. The firm had revenue of $120.33 million for the quarter, compared to analyst estimates of $119.98 million. Phreesia had a negative return on equity of 1.31% and a negative net margin of 1.16%.Phreesia’s revenue was up 12.7% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.25) EPS. As a group, equities research analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current year.

Analysts Set New Price Targets

Several research analysts recently weighed in on PHR shares. Canaccord Genuity Group cut their target price on shares of Phreesia from $38.00 to $33.00 and set a “buy” rating for the company in a research note on Tuesday, December 9th. DA Davidson lifted their price target on shares of Phreesia from $33.00 to $35.00 and gave the stock a “buy” rating in a report on Tuesday, December 2nd. Weiss Ratings reissued a “sell (e+)” rating on shares of Phreesia in a research note on Friday, October 31st. Robert W. Baird decreased their target price on shares of Phreesia from $31.00 to $25.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 10th. Finally, Truist Financial set a $24.00 price target on Phreesia in a report on Thursday. Seventeen analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $30.06.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the company. Squarepoint Ops LLC boosted its holdings in Phreesia by 243.6% in the second quarter. Squarepoint Ops LLC now owns 100,922 shares of the company’s stock valued at $2,872,000 after acquiring an additional 71,553 shares during the last quarter. Farther Finance Advisors LLC raised its holdings in shares of Phreesia by 9,375.0% in the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock worth $86,000 after purchasing an additional 3,000 shares during the period. Arcadia Investment Management Corp MI lifted its stake in shares of Phreesia by 22.3% in the 2nd quarter. Arcadia Investment Management Corp MI now owns 113,470 shares of the company’s stock valued at $3,229,000 after purchasing an additional 20,700 shares in the last quarter. Acadian Asset Management LLC grew its holdings in shares of Phreesia by 61.6% during the 2nd quarter. Acadian Asset Management LLC now owns 364,194 shares of the company’s stock worth $10,357,000 after purchasing an additional 138,877 shares during the period. Finally, Boston Partners grew its holdings in shares of Phreesia by 165.1% during the 2nd quarter. Boston Partners now owns 130,060 shares of the company’s stock worth $3,702,000 after purchasing an additional 81,006 shares during the period. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.